These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1801354)

  • 41. Immunogenicity and reactogenicity of two recombinant hepatitis B vaccines in small infants: a randomized, double-blind comparative study.
    Sapru A; Kulkarni PS; Bhave S; Bavdekar A; Naik SS; Pandit AN
    J Trop Pediatr; 2007 Oct; 53(5):303-7. PubMed ID: 17478542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on the status of immune memory after completion of hepatitis B vaccination].
    Li YP; Li RC; Fang KX; Li HM; Hu ZY; He P; Wu XY; Zhang R; Liang ZL; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):319-21. PubMed ID: 17850693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
    Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 2-dose regimen of a recombinant hepatitis B vaccine with the immune stimulant AS04 compared with the standard 3-dose regimen of Engerix-B in healthy young adults.
    Levie K; Gjorup I; Skinhøj P; Stoffel M
    Scand J Infect Dis; 2002; 34(8):610-4. PubMed ID: 12238579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of vertical transmission of hepatitis B virus by yeast recombinant hepatitis B vaccine.
    Murata R; Isshiki G; Yoshioka H; Chiba Y; Tada H; Koike M; Kimura M
    Acta Paediatr Jpn; 1989 Apr; 31(2):180-5. PubMed ID: 2516698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
    Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
    Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antibody reaction to immunization with different recombinant hepatitis B vaccine in primary school children].
    Liang Z; Li C; Jing Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1998 May; 32(3):165-7. PubMed ID: 10322792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Interruption of perinatal transmission of HBV by Chinese recombinant hepatitis B vaccine].
    Yang C; Chen D; Li S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):343-5. PubMed ID: 7874702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
    Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safety and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in renal pre-dialysis and dialysis patients.
    Gilbert CL; Stek JE; Villa G; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Vaccine; 2014 Nov; 32(48):6521-6. PubMed ID: 25252192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.
    Yao J; Shan H; Chen Y; Jiang ZG; Dai XW; Ren JJ; Xu KJ; Ruan B; Yang SG; Li Q
    Hum Vaccin Immunother; 2015; 11(5):1114-9. PubMed ID: 25692413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up].
    Zhang L; Zhang W; Lyu JJ; Zhang JJ; Liu JY; Yan BY; Feng Y; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1156-1160. PubMed ID: 28910922
    [No Abstract]   [Full Text] [Related]  

  • 55. The effects of booster vaccination of hepatitis B vaccine on anti-HBV surface antigen negative children 11-15 years after primary vaccination.
    Yao J; Ren J; Shen L; Chen Y; Liang X; Cui F; Li Q; Jiang Z; Wang F
    Hum Vaccin; 2011 Oct; 7(10):1055-9. PubMed ID: 21989290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants.
    Ayoola EA; Johnson AO
    Int J Gynaecol Obstet; 1987 Aug; 25(4):297-301. PubMed ID: 2887464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.
    Prinsen H; Goilav C; Safary A; André FE; Piot P
    Postgrad Med J; 1987; 63 Suppl 2():147-9. PubMed ID: 3317352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers.
    Young BW; Lee SS; Lim WL; Yeoh EK
    J Viral Hepat; 2003 Jan; 10(1):23-30. PubMed ID: 12558908
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of hepatitis B virus (HBV) vaccine in long term prevention of HBV infection.
    Pongpipat D; Suvatte V; Assatteerawats A
    Asian Pac J Allergy Immunol; 1988 Jun; 6(1):19-22. PubMed ID: 3166643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dynamic study on the anti-HBs level of immunized children born to HBsAg-positive and HBsAg-negative mothers in hyperendemic area of hepatitis B].
    Gong J; Li RC; Li YP; Yang JY; Chen XR; Nong Y; Huang ZN; Li Q; Liu CB; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jan; 29(1):13-6. PubMed ID: 18785470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.